Composition
- Active ingredients
- NIMODIPINE 3MG/ML
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- NIMODIPINE 30MG · CapsuleANDA076740-001 · Prescription
- NIMODIPINE 60MG/10ML · SolutionANDA213409-002 · Tentative approval
- NIMODIPINE 6MG/ML · SolutionANDA213409-001 · Prescription
- NIMODIPINE 30MG · CapsuleANDA077811-001 · Prescription
- NIMODIPINE 30MG · CapsuleANDA090103-001 · Prescription
- NIMODIPINE 30MG · CapsuleANDA201832-001 · Discontinued
- NIMODIPINE 30MG · CapsuleANDA077067-001 · Discontinued
- NIMODIPINE 3MG/ML · SolutionThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA216937.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Nimodipine
- Route
- Oral
- Dosage form
- Solution
- Applicant
- Annora Pharma
- Status
- Prescription
- FDA approval
- 9 Jul 2024
- Application
- ANDA216937-001